LIGAND PHARMACEUTICALS INCORPORATED Lessee, Operating Lease, Liability, to be Paid, after Year Five
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) had Lessee, Operating Lease, Liability, to be Paid, after Year Five of $1.25 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive · last filed 2026-02-27
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $1.25M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $2.00M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $2.91M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $7.61M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, after Year Five |
|---|---|
| 2025-12-31 | $1.25M 10-K · filed 2026-02-27 |
| 2024-12-31 | $2.00M 10-K · filed 2025-02-28 |
| 2023-12-31 | $2.91M 10-K · filed 2024-02-29 |
| 2022-12-31 | $7.61M 10-K · filed 2023-02-28 |
| 2022-09-30 | $22.32M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $14.76M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $8.07M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $10.83M 10-K · filed 2022-02-28 |
| 2020-12-31 | $700.00K 10-K · filed 2021-02-24 |
| 2019-12-31 | $3.49M 10-K · filed 2020-02-27 |
| 2019-09-30 | $5.26M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $5.35M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.92M 10-Q · filed 2019-05-09 |